<

 
Data updated 2025-08-01 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date10709360.1 (espacenet)  (Federated)  (European Patent Register), 20100312
Patent/reg. no. and dateDK/EP 2406629, 20130918
Publication date20120118
Priority no. and dateUS 160217 P, 20090313
EP pub. no. and date EP 2406629 20120118
Effective date
Applicant/ownerAllergan, Inc., 2525 Dupont Drive
Irvine, CA 92612, US
Applicant ref. no.V1026DK00
InventorFernandez-Salas, Ester, 1710 Rocky Road
Fullerton
CA 92831, US,
ZHU, Hong, 11408 Pacific Shores Way
San Diego
CA 92130, US,
WANG, Joanne, 37 Bristlecone
Irvine
CA 92620, US,
HODGES, D., Diane, 14351 Pinewood Road
Tustin
CA 92780, US
RepresentativeGUARDIAN IP CONSULTING I/S, Diplomvej 381, 2800 Kongens Lyngby, DK
Opponent
IPC ClassC12Q 1/37 (2006.01) , G01N 33/50 (2006.01) 
TitleIMMUNBASEREDE RETARGETED ENDOPEPTIDASEAKTIVITETSASSAYS
Int. application no.US2010027244
Int. publication no.WO2010105236
Related patent (certificate)
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact